Prospective Two-Year cohort study of surgical and implant predictors of breast implant displacement and rotation after aesthetic augmentation
NCT ID NCT07810270
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
This prospective inception cohort will follow women for ten years after primary or revision aesthetic breast implantation. Pocket plane, incision route, implant texture, shape, volume, and operative pocket variables will be recorded. Standardized clinical and photographic assessments will identify displacement and rotation. The primary outcome is time to clinically significant implant malposition or rotation; direction, reoperation, patient-reported outcomes, and early postoperative predictors will also be analyzed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2014
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult women undergoing primary or revision aesthetic breast implantation with complete operative and device documentation.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female sex and age 18 years or older. * Primary or revision aesthetic breast implantation with a permanent implant. * Complete documentation of pocket plane, incision route, texture, shape, volume, laterality, and operative pocket measurements. * Standardized early postoperative baseline photography and clinical position assessment. * Ability to complete follow-up through 24 months. * Written informed consent. Exclusion Criteria: * Reconstructive implantation after mastectomy or major trauma. * Tissue expander. * Immediate major postoperative complication requiring implant removal before the position baseline can be established; these cases remain in safety reporting but not the position-risk cohort. * Missing operative or device variables. * Inability to obtain standardized photographs or position measurements. * Planned pregnancy during the first 12 months if the final protocol elects to exclude it.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast implant malposition are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
IQ interquirofanos
RECRUITINGMedellín, Colombia